Performance Improvement Strategies in Myelodysplastic Syndromes

A complimentary, certified PI CME Program to help health care providers implement guideline-based processes of care for patients with MDS, with special emphasis on patient evaluation and disease classification, evidence-based surveillance and supportive care, and evidence-based treatment.

Earn up to 20 AMA PRA Category 1 Credits™ and use your data to earn credit for ABIM Maintenance of Certification (MOC).

Upon completion, participants should be able to:

• Identify the clinical significance of abnormalities in laboratory findings of peripheral blood
• Use classification systems to stratify patients and assess the benefits of therapies within prognostic subsets
• Apply current evidence to provide high-quality diagnostic and therapeutic care for patients with MDS

PI-CME is an AMA-standardized, three-stage initiative that has been recognized as an important component of continuing professional development and may meet multiple credentialing and reporting needs.

Faculty:
Mikkael A. Sekeres, MD
Associate Professor of Medicine
Director, Leukemia Program
Cleveland Clinic Taussig Cancer Institute
Department of Hematologic Oncology and Blood Disorders

Guillermo Garcia-Manero, MD
Professor of Medicine
Chief, Section of MDS
Department of Leukemia
The University of Texas MD Anderson Cancer Center